| Pharmaceutical Information |
| Drug Name |
Tetraferric tricitrate decahydrate |
| Drug ID |
BADD_D02184 |
| Description |
Tetraferric tricitrate decahydrate is an iron containing phosphate binder used to treat hyperphosphatemia and iron deficiency anemia in adults with chronic kidney disease.[A25965]
Tetraferric tricitrate decahydrate was granted FDA approval on 5 September 2014.[L9926] |
| Indications and Usage |
Tetraferric tricitrate decahydrate is indicated to control serum phosphorous in adults with chronic kidney disease who require dialysis.[L9926] Tetraferric tricitrate decahydrate is also indicated to treat iron deficiency anemia in adults with chronic kidney disease who are not on dialysis.[L9926] |
| Marketing Status |
approved |
| ATC Code |
V03AE08 |
| DrugBank ID |
DB14520
|
| KEGG ID |
Not Available
|
| MeSH ID |
Not Available
|
| PubChem ID |
90478690
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
63474-300 |
| UNII |
Q91187K011
|
| Synonyms |
Not Available |
|
| Chemical Information |
| Molecular Formula |
C18H32Fe4O31 |
| CAS Registry Number |
Not Available |
| SMILES |
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])[O-].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])[O-
].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])[O-].O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe
+3].[Fe+3] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
